Eli Lilly and Co. and its peers might be back in Congress’ sights as lawmakers hunt for more ways to cut health care
costs. A new study in the influential Health Affairs journal concludes that European drugmakers operating
in markets with pharmaceutical price controls have produced proportionally more innovations than their U.S. counterparts.
If President Barack Obama gets what he wants in his health care plan — covering all Americans and barring insurers from
denying coverage — some analysts say individuals could wind up paying higher premiums.
Indiana Gov. Mitch Daniels outlined his concerns about some of the health care proposals being debated in Congress in a letter
sent to the state’s congressional delegation and released by his office yesterday.
If Congress implements a new system of health insurance exchanges across the country, Indianapolis benefits broker Joe
Guzman is confident he and his peers would take a hit.
Nine months after being suspended as a contractor for the federal Medicare program, WellPoint Inc. is back in the game.
Indianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
With job growth surging in Warsaw’s orthopedic cluster, the life sciences development group BioCrossroads Inc. set out to…
Eli Lilly and Co. paid doctors in South Carolina for participating in a speakers’ program in exchange for prescribing the
antipsychotic Zyprexa, according to notes by Lilly sales representatives reviewed by Bloomberg News.
Heartland Sweeteners LLC is now a top maker of private-label alternatives to Splenda. The company also
markets its own products directly to consumers.
German group invests in Carmel-based company that specializes in financial services for insurance agencies.
A co-founder of Hall Render Killian Heath & Lyman PC is returning to the downtown law firm more than a decade after
he left it. Rex Killian will lead the firm’s governance consulting practice, which serves both not-for-profit
and for-profit health care clients.
The Indianapolis-based Indiana Health Information Exchange today began sharing electronic medical records with two similar
organizations across a multi-regional network, the group announced this morning.
A consumer group says health insurers UnitedHealth and WellPoint pressured their employees to contact members of Congress
and lobby against health care reform proposals that the companies disagreed with.
Pfizer Inc., the world’s largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription
drug promotions, the Justice Department announced today.
Conseco Inc. this morning said it is consolidating three of its insurers into one, a move that will have no impact on employment
but will save the company about $2.5 million annually.
The St. Francis hospital system has reached a tentative contract agreement with Anthem Blue Cross and Blue Shield of Indiana,
ending a disagreement over insurance reimbursement costs, the parties said today.
Locally based venture capital firms Cardinal Equity Partners and Centerfield Capital Partners have joined with Chicago-based
bank Harris NA to recapitalize the state’s largest independent physical therapy provider.
Jerome Peribere shifted Dow AgroScience’s focus toward what he calls “revolutionary solutions."
WellPoint Inc., the nation’s largest health insurer based on membership, spent $1.2 million in the second quarter to lobby
the federal government on a variety of health care reform-related issues and other topics, according to a recent disclosure
report.
Drugmaker Eli Lilly and Co. spent nearly $3.6 million in the second quarter lobbying the federal government on health care
reform and trademark issues, among other topics, according to a recent disclosure form.
